Projects per year
Search results
-
Not started
A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma.
Roberts, S. (Primary Chief Investigator (PCI)), Lewis, P. (Project Manager), Matos, M. (Chief Investigator (CI)), Zekry, A. (Chief Investigator (CI)) & Haridy, J. (Chief Investigator (CI))
Project: Research
-
Discovery and validation of biomarkers for nonalcoholic steatohepatitis and liver fibrosis
Watt, M. (Primary Chief Investigator (PCI)), Montgomery, M. K. (Chief Investigator (CI)), Burton, P. (Chief Investigator (CI)), Brown, W. (Chief Investigator (CI)), Roberts, S. (Chief Investigator (CI)), Kemp, W. (Chief Investigator (CI)) & Earnest, A. (Associate Investigator (AI))
Project: Research
-
A Phase 1/2a - Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects With Chronic Hepatitis B Infection, Including Subjects With Chronic Hepatitis D Infection
Roberts, S. (Primary Chief Investigator (PCI))
Project: Research